FDA 510(k)
FDA class 2
Substantially Equivalent
🇺🇸 United States
SERAQUEST ANTI-THYROGLOBULIN
K Number: K023592
·
Decision Jan 6, 2003
Classifications
1
FEI Numbers
11
Registration Numbers
11
Same Product Code
12
Applicant Total
25
Review Days
73
Research this 510(k) in seconds
The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.
Free to try · every answer cites its records
Basic Information
- Device Name
- SERAQUEST ANTI-THYROGLOBULIN
- K Number
- K023592
- Device Class
- FDA class 2
- Clearance Type
- Traditional
- Regulation Number
- 866.5870
- Medical Specialty
- Immunology
- Decision
- Substantially Equivalent
- Statement or Summary
- Summary
- Applicant
- Quest Intl., Inc.
- Date Received
- October 25, 2002
- Decision Date
- January 6, 2003
- Product Code
- DDC
- Advisory Committee
- Immunology
- Review Advisory Committee
- IM
- Third Party
- N
Classifications
This FDA 510(k) entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| DDC | Thyroglobulin, Antigen, Antiserum, Control | FDA class 2 | Immunology |
Similar 510(k) Clearances
Other 510(k) clearances with the same product code (DDC), ordered by most recent decision date.
ACCESS THYROGLOBULIN ANTIBODY AND CALIBRATORS ON THE ACCESS IMMUNOASSAY SYSTEMS, MODELS 33890, 33895
FDA 510(k)
FDA Class 2
·Immunology
MODIFICATION TO ZEUS SCIENTIFIC, INC., THYROGLOBULIN IGG ELISA TEST SYSTEM
FDA 510(k)
FDA Class 2
·Immunology
ZEUS SCIENTIFIC INC., TPO IGG ELISA TEST SYSTEM.
FDA 510(k)
FDA Class 2
·Immunology
ZEUS SCIENTIFIC, INC., THYROGLOBULIN IGG ELISA TEST SYSTEM
FDA 510(k)
FDA Class 2
·Immunology
ANTI-THYROGLOBULIN (TG) MICROPLATE ELISA
FDA 510(k)
FDA Class 2
·Immunology
SERODIA ATG
FDA 510(k)
FDA Class 2
·Immunology
Other Clearances by Quest Intl., Inc.
| K Number | Device Name | ||
|---|---|---|---|
| K091260 | SERAQUEST EBV EA-D IGG TEST | Jun 8, 2009 | Substantially Equivalent |
| K033915 | MODIFICATION TO SERAQUEST EB VCA IGG | Jan 16, 2004 | Substantially Equivalent |
| K033780 | MODIFICATION TO SERAQUEST VCA IGM | Jan 15, 2004 | Substantially Equivalent |
| K023593 | SERAQUEST ANTI-THYROID PEROXIDASE (TPO) | Feb 6, 2003 | Substantially Equivalent |
| K003069 | ANTI-CARDIOLIPIN, MULTIPLE AUTOANTIBODIES IMMUNOLOGICAL TEST SYSTEM | Nov 27, 2000 | Substantially Equivalent |
| K991975 | SERAQUEST EB NA IGG | Nov 2, 1999 | Substantially Equivalent |
| K990410 | SERAQUEST EB VCA IGG | Oct 28, 1999 | Substantially Equivalent |
| K990977 | SERAQUEST EB VAC IGM | Oct 6, 1999 | Substantially Equivalent |
| K982485 | SERAQUEST CMV IGM | Jan 13, 1999 | Substantially Equivalent |
| K982281 | SERAQUEST RUBELLA IGM | Oct 16, 1998 | Substantially Equivalent |